SynthesisFrontiers in pharmacology2023

Risk of diabetic ketoacidosis of SGLT2 inhibitors in patients with type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials.

Shiwen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.